🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#EASLStudio is starting now! Join the faculty for a fascinating discussion on the cases of #AIH following #Covid_19 vaccination Ahmed Elsharkawy Vlad Ratziu Naga Chalasani Fernando Bril EASLnews Journal of Hepatology 🔗easl.eu/easl-studio-ep… #LiverTwitter #AutoimmuneHepatitis

Read a recap if you missed the session at #ADA. #NAFLD #NASH

🤭Want to know the performance of different strategies to select patients at high risk of advanced #liver #fibrosis for #screening using #noninvasive tools? ➡️#metabolic approach ➡️#imaging approach ➡️liver #biochemistry approach ... ✔️Get details from: mtodjournal.net/article/view/5…

The mechanisms linking #NASH #AdvancedFibrosis and heart disease remain unclear. In this work, we showed that changes in HDL proteins may explain, at least in part, this relationship. Published at #JCEM. You cannot miss it! academic.oup.com/jcem/advance-a… UAB Endocrinology Diabetes and Metabolism UAB Medicine

Discontinuation of #pioglitazone in patients with biopsy-proven #NASH was associated with biochemical worsening of the disease. Fernando Bril pubmed.ncbi.nlm.nih.gov/36495442/

Patients with non-alcoholic fatty #liver disease with advanced #fibrosis show significant differences in #HDL-bound protein levels, and this translates into increased cardiovascular risk. Featured study in #JCEM. #CVD Endocrine Society doi.org/10.1210/clinem…

It was an honor writing this review article on the relationship between #NASH and the #metabolicsyndrome with Drs. Ken Cusi and Arun Sanyal, 2 leaders in the field of #NAFLD. Download, read, and share! authors.elsevier.com/a/1gfXt3tho0co…

Linked Comment by Fernando Bril - Semaglutide in NASH-related cirrhosis: too late to the party? thelancet.com/journals/langa… #NASH #cirrhosis #livertwitter #NAFLD Fernando Bril

Semaglutide 2·4 mg weekly in NASH-cirrhosis: a randomised, placebo-controlled phase 2 trial. thelancet.com/journals/langa… Is it too late at this point to improve liver fibrosis? Do NOT miss my editorial: thelancet.com/journals/langa…

Fascinating case reports describing post-COVID Lipoprotein X. Well done, informative and easy to read. From Jennifer Girard, Courtney Wagner, MD Sujan Ravi Monica Agarwal MD, MEHP, FACE Fernando Bril. doi.org/10.1016/j.aace…

Contributions welcome: oaemesas.com/login?JournalI… Jose M. Balibrea MD, PhD, FACS Jordi Tarascó, MD PhD @ricardcorcelles Farah Husain MD, FACS, FASMBS Cristobal Morales Chetan D Parmar Karl Nadolsky

Welcome share and down it: f.oaes.cc/xmlpdf/afaafce… Prof. Dr. Sanjeev Bagai Elena Armeni

Welcome to share and read the article: f.oaes.cc/xmlpdf/793cc4b… @drpaulfriedman Liverpool Centre for Cardiovascular Science Gervasio Lamas MD Harry Spoelstra

Presenting at #ENDO2023 Endocrine Society our study on the association of free fatty acids with liver mitochondrial function. UAB Endocrinology Diabetes and Metabolism

Check out our recently published review on Adipose Tissue Dysfunction in Polycystic Ovary Syndrome at Endocrine Society Journals Endocrine Society #JCEM #PCOS #NAFLD academic.oup.com/jcem/article-a…

Still celebrating the U.S. News & World Report's ranking of UAB Hospital’s diabetes and endocrinology specialty at number 39 in the nation. Congrats UAB Endocrinology Diabetes and Metabolism ! 🥳 Proud to support clinical efforts through #diabetesresearch.

Presenting our work at #TLM2023 AASLD... Thanks to AASLD Foundation for the abstract award! Excellent meeting as usual!

Noninvasive tests to identify liver fibrosis in #MASLD are affected by race. Fernando Bril …ary-wiley-com.proxy.library.emory.edu/doi/full/10.10…

🎉 Exciting News! Congratulations to M&TOD for achieving a stellar CiteScore of 3.2. 📚 This accomplishment reflects the dedication of our incredible scholars. Big thanks to all contributors! Here's to even greater achievements in 2024! 🙌More details:scopus.com/sourceid/21101…

📣"Our results suggest that we may need to move toward including [race and ethnicity] when noninvasively assessing the risk of liver fibrosis." Read more ⬇️ Fernando Bril Meagan Gray UAB Department of Medicine UAB Comprehensive Diabetes Center UAB Endocrinology Diabetes and Metabolism Healio Gastroenterology healio.com/news/endocrino…